Global Autoimmune Disease Diagnosis Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Autoimmune Disease Diagnosis Market Analysis

  • Healthcare
  • Upcoming Report
  • Apr 2024
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Frequently Asked Questions

The market is segmented based on , By Product and Service (Consumables & Assay Kits, Instruments, and Services), Test (Routine Laboratory Tests, Inflammatory Markets, Autoantibodies and Immunologic Tests, and Others), Disease (RA, SLE, Thyroiditis, and Scleroderma), End User (Hospitals and Clinical Labs) – Industry Trends and Forecast to 2031. .
The Global Autoimmune Disease Diagnosis Market size was valued at USD 5.29 USD Billion in 2023.
The Global Autoimmune Disease Diagnosis Market is projected to grow at a CAGR of 8.15% during the forecast period of 2024 to 2031.
The major players operating in the market include , Siemens AG , Abbott , Thermo Fisher Scientific , Danaher , GRIFOLS , Bio,Rad Laboratories , Protagen AG , HYCOR , Nova Diagnostics , Trinity Biotech , EUROIMMUN AG , Quest Diagnostics , Hemagen Diagnostics , Crescendo Bioscience , AESKU GROUP GmbH , SQI Diagnostics , Seramun Diagnostica GmbH , Myriad Genetics , Omega Diagnostics Group PLC , ORGENTEC DIagnostika,.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa.